Anika Therapeutics Inc. 10Y Operating CF Growth (CAGR)

10Y Operating CF Growth (CAGR) of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including 10Y Operating CF Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 10Y Operating CF Growth (CAGR) for 2021 was -0.15% (a -102.37% decrease from previous year)
  • Annual 10Y Operating CF Growth (CAGR) for 2020 was 6.33% (a -77.81% decrease from previous year)
  • Annual 10Y Operating CF Growth (CAGR) for 2019 was 28.53% (a 18920.0% increase from previous year)
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 10Y Operating CF Growth (CAGR) of Anika Therapeutics Inc.

Most recent 10Y Operating CF Growth (CAGR)of ANIK including historical data for past 10 years.

Interactive Chart of 10Y Operating CF Growth (CAGR) of Anika Therapeutics Inc.

Anika Therapeutics Inc. 10Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -0.15%
2020 6.33%
2019 28.53%
2011 0.15%

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices